Messoud Ashina
@messoudashina
Professor of Neurology, Danish Headache Center, Head of Danish Knowledge Center on Headache Disorders, Past President of the International Headache Society
ID: 4725243623
http://hmru.dk 06-01-2016 14:03:54
585 Tweet
1,1K Takipçi
63 Takip Edilen
Hot off the press 🗞️ Upregulation of intracellular cAMP triggers migraine-like headache in people with post-traumatic headache 🧠 Could targeting cAMP-dependent signaling be the key to pain relief? 🧐🧠 Read more here: …alofheadacheandpain.biomedcentral.com/articles/10.11… Hakan Ashina Haidar Al-Khazali
🚀 Exciting News! Can blocking CGRP improve rosacea symptoms? Check out this study on erenumab's effectiveness in reducing flushing and erythema in #rosacea patients. International Headache Society JAMA Dermatology AAD EADV Human Migraine Research Unit jamanetwork.com/journals/jamad…
🧠 New Insights Alert! 🧠 Discover how migraine reshapes the brain! Differences in Cortical Morphology in People With and Without Migraine. International Headache Society Lundbeckfonden European Headache Federation Rigshospitalet American Migraine Foundation neurology.org/doi/10.1212/WN…
Leading researcher Messoud Ashina explains what #PACAP is, its role in migraine pathophysiology, how it differs from #CGRP, and its potential as a target for #migraine and other #headache disorders. Watch the full video or the transcript at migrainedisorders.org/podcast/s6ep5-…
🧠💊 New study: a non-vascular KATP channel opener doesn’t trigger migraine attacks! This suggests targeting 👉vascular 👈KATP channels may be key for migraine treatment. 🚫🤕International Headache Society Lundbeckfonden European Headache Federation journals.sagepub.com/doi/10.1177/03…
Comprehensive review on Trigeminal Neuralgia in Nature Reviews Disease Primers highlights complex pathophysiology, diagnosis, & treatment challenges, effect on quality of life with variable incidence, genetic factors, & diverse treatment approaches #TrigeminalNeuralgia👇 rb.gy/phcni4
Saturday news 🗞️ New study in Cephalalgia reveals migraine attack induction via cGMP-dependent signaling can occur even during #CGRP receptor blockade using #erenumab🧠 Read more: journals.sagepub.com/doi/10.1177/03… Bianca Raffaelli Messoud Ashina Hakan Ashina
Dr. T Monteith talks with Dr. M Ashina about the comparison btw cortical morphometry to a large sample of people with migraine and healthy controls, as well as across migraine subtypes.Teshamae Monteith, M.D. American Academy of Neurology European Academy of Neurology podcasts.apple.com/dk/podcast/neu…
🔬 New research paper finds hypersensitivity to BKCa channel opening in people with post-traumatic headache🧠 Targeting BKCa channels might open new avenues for drug discovery 💊Hakan Ashina Haidar Al-Khazali Basit Ali Chaudhry Read more here: …alofheadacheandpain.biomedcentral.com/articles/10.11…
Activation of the Kir6.2/SUR1 channel doesn't trigger migraine, suggesting it isn't involved in migraine. Study indicate that KATP channel blockers targeting Kir6.1/SUR2B in cerebral blood vessels could be new treatments. doi.pulse.ly/ajxqswgc2y Lili Kokoti Messoud Ashina Faisal Mohammad Amin
🎉 Great news for children & adolescents! 🎉 Teva's Phase 3 SPACE trial shows fremanezumab significantly reduces monthly migraine days for kids aged 6-17! 🧒👧 Safe and effective with no new safety signals. 🌟 Human Migraine Research Unit International Headache Society businesswire.com/news/home/2024…
Rogelio has completed his PhD fellowship at Human Migraine Research Unit . After 3 years of dedicated work in our lab, he is returning to Mexico to continue his career as a neurologist. We wish him all the best in his future endeavors! 🇩🇰❤️🇲🇽
Congratulations to Hashmat Ghanizada, MD, PhD on completing his postdoc BRIDGE program! 🎉 This is a significant milestone in his career. Wishing him continued success in all his future endeavors! 🙏🎗️to Novo Nordisk Foundation UCPH SUND R&I
Levcromakalim does not induce migraine aura in participants with aura without headache. It likely induces migraine aura via effects on the trigeminovascular system rather than induction of CSD. journals.sagepub.com/doi/10.1177/03… Human Migraine Research Unit Messoud Ashina Mohammad Al-Mahdi Anders Hougaard
🚨 New hope for people with migraine! A Phase 2 study shows that a monoclonal antibody against PACAP reduces migraine days. 🌟Rigshospitalet International Headache Society Lundbeckfonden Human Migraine Research Unit European Headache Federation nejm.org/doi/full/10.10…
🧠The signaling molecule PACAP plays a key role in triggering migraine attacks. Discover how PACAP could reshape migraine treatment and bring relief to those in need 💡👇Human Migraine Research Unit International Headache Society European Academy of Neurology European Headache Federation nature.com/articles/s4158…
Neurology Podcast: Dr. Tesha Monteith & Dr. Messoud Ashina discuss the biology of PACAP, its significance in relation to #migraines, and its potential as a novel therapeutic approach. Listen now: bit.ly/3AXNRqq Messoud Ashina Teshamae Monteith, M.D.